Stocks
TuHURA Biosciences, Inc.HURA
NASDAQHealthcareBiotechnology$1.90-3.06%
A clinical-stage biopharmaceutical company focused on developing immunotherapies to address unmet medical needs in oncology and autoimmune diseases. Its pipeline includes novel immune-modulating therapies, attracting investor interest due to its potential in high-growth therapeutic areas.
Market Cap: $107.3M52W Range: $0.41 – $4.44
Congressional Interest in TuHURA Biosciences, Inc. (HURA)
1 member of Congress has disclosed 4 trades in TuHURA Biosciences, Inc. (HURA), a Healthcare company. The buy/sell breakdown shows 3 purchases versus 0 sales, indicating net buying interest from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
4
Unique Politicians
1
Buys
3
Sells
0
Who in Congress Is Trading HURA?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2025-07-13 | Laurel Lee | buy | $50K – $100K |
| 2024-11-25 | Laurel Lee | buy | $1K – $15K |